APO Research

APO RESEARCH · REPORT

Lansoprazole for Injection

Selected research

Market Analysis & Forecast

Global Lansoprazole for Injection Market Analysis and Forecast 2026-2032

Market perspective

The global Lansoprazole for Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lansoprazole for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lansoprazole for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lansoprazole for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lansoprazole for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Lansoprazole for Injection include Maya Biotech, Chengdu Baiyu Pharmaceutical, Jiangsu Aosaikang Pharmaceutical, Luoxin Pharmaceutical, Takeda and Yuekang Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lansoprazole for Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lansoprazole for Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Lansoprazole for Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lansoprazole for Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lansoprazole for Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lansoprazole for Injection sales, projected growth trends, production technology, application and end-user industry.

Lansoprazole for Injection Segment by Company

Maya Biotech

Chengdu Baiyu Pharmaceutical

Jiangsu Aosaikang Pharmaceutical

Luoxin Pharmaceutical

Takeda

Yuekang Pharmaceutical

Lansoprazole for Injection Segment by Type

Vial Type

Ampule Type

Lansoprazole for Injection Segment by Application

Male

Female

Lansoprazole for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lansoprazole for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lansoprazole for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lansoprazole for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Lansoprazole for Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Lansoprazole for Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lansoprazole for Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lansoprazole for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Vial Type Major Manufacturers Table 3. Ampule Type Major Manufacturers Table 4. Global Lansoprazole for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Male Major Manufacturers Table 6. Female Major Manufacturers Table 7. Lansoprazole for Injection Industry Trends Table 8. Lansoprazole for Injection Industry Drivers Table 9. Lansoprazole for Injection Industry Opportunities and Challenges Table 10. Lansoprazole for Injection Industry Restraints Table 11. Global Lansoprazole for Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Lansoprazole for Injection Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Lansoprazole for Injection Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Lansoprazole for Injection Revenue Market Share by Region (2021-2026) Table 15. Global Lansoprazole for Injection Revenue Market Share by Region (2027-2032) Table 16. Global Lansoprazole for Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Lansoprazole for Injection Sales by Region (2021-2026) & (K Units) Table 18. Global Lansoprazole for Injection Sales by Region (2027-2032) & (K Units) Table 19. Global Lansoprazole for Injection Sales Market Share by Region (2021-2026) Table 20. Global Lansoprazole for Injection Sales Market Share by Region (2027-2032) Table 21. Global Lansoprazole for Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Lansoprazole for Injection Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Lansoprazole for Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Lansoprazole for Injection Sales Market Share by Manufacturers (2021-2026) Table 25. Global Lansoprazole for Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Lansoprazole for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Lansoprazole for Injection Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Lansoprazole for Injection Manufacturers, Product Type & Application Table 29. Global Lansoprazole for Injection Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Lansoprazole for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Lansoprazole for Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Lansoprazole for Injection Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Lansoprazole for Injection Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Lansoprazole for Injection Revenue Market Share by Type (2021-2026) Table 36. Global Lansoprazole for Injection Revenue Market Share by Type (2027-2032) Table 37. Global Lansoprazole for Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Lansoprazole for Injection Sales by Type (2021-2026) & (K Units) Table 39. Global Lansoprazole for Injection Sales by Type (2027-2032) & (K Units) Table 40. Global Lansoprazole for Injection Sales Market Share by Type (2021-2026) Table 41. Global Lansoprazole for Injection Sales Market Share by Type (2027-2032) Table 42. Global Lansoprazole for Injection Price by Type (2021-2026) & (US$/Unit) Table 43. Global Lansoprazole for Injection Price by Type (2027-2032) & (US$/Unit) Table 44. Global Lansoprazole for Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Lansoprazole for Injection Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Lansoprazole for Injection Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Lansoprazole for Injection Revenue Market Share by Application (2021-2026) Table 48. Global Lansoprazole for Injection Revenue Market Share by Application (2027-2032) Table 49. Global Lansoprazole for Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Lansoprazole for Injection Sales by Application (2021-2026) & (K Units) Table 51. Global Lansoprazole for Injection Sales by Application (2027-2032) & (K Units) Table 52. Global Lansoprazole for Injection Sales Market Share by Application (2021-2026) Table 53. Global Lansoprazole for Injection Sales Market Share by Application (2027-2032) Table 54. Global Lansoprazole for Injection Price by Application (2021-2026) & (US$/Unit) Table 55. Global Lansoprazole for Injection Price by Application (2027-2032) & (US$/Unit) Table 56. Maya Biotech Company Information Table 57. Maya Biotech Business Overview Table 58. Maya Biotech Lansoprazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Maya Biotech Lansoprazole for Injection Product Portfolio Table 60. Maya Biotech Recent Development Table 61. Chengdu Baiyu Pharmaceutical Company Information Table 62. Chengdu Baiyu Pharmaceutical Business Overview Table 63. Chengdu Baiyu Pharmaceutical Lansoprazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Chengdu Baiyu Pharmaceutical Lansoprazole for Injection Product Portfolio Table 65. Chengdu Baiyu Pharmaceutical Recent Development Table 66. Jiangsu Aosaikang Pharmaceutical Company Information Table 67. Jiangsu Aosaikang Pharmaceutical Business Overview Table 68. Jiangsu Aosaikang Pharmaceutical Lansoprazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Jiangsu Aosaikang Pharmaceutical Lansoprazole for Injection Product Portfolio Table 70. Jiangsu Aosaikang Pharmaceutical Recent Development Table 71. Luoxin Pharmaceutical Company Information Table 72. Luoxin Pharmaceutical Business Overview Table 73. Luoxin Pharmaceutical Lansoprazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Luoxin Pharmaceutical Lansoprazole for Injection Product Portfolio Table 75. Luoxin Pharmaceutical Recent Development Table 76. Takeda Company Information Table 77. Takeda Business Overview Table 78. Takeda Lansoprazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Takeda Lansoprazole for Injection Product Portfolio Table 80. Takeda Recent Development Table 81. Yuekang Pharmaceutical Company Information Table 82. Yuekang Pharmaceutical Business Overview Table 83. Yuekang Pharmaceutical Lansoprazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Yuekang Pharmaceutical Lansoprazole for Injection Product Portfolio Table 85. Yuekang Pharmaceutical Recent Development Table 86. North America Lansoprazole for Injection Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Lansoprazole for Injection Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Lansoprazole for Injection Sales by Type (2021-2026) & (K Units) Table 89. North America Lansoprazole for Injection Sales by Type (2027-2032) & (K Units) Table 90. North America Lansoprazole for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 91. North America Lansoprazole for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 92. North America Lansoprazole for Injection Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Lansoprazole for Injection Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Lansoprazole for Injection Sales by Application (2021-2026) & (K Units) Table 95. North America Lansoprazole for Injection Sales by Application (2027-2032) & (K Units) Table 96. North America Lansoprazole for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 97. North America Lansoprazole for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 98. North America Lansoprazole for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Lansoprazole for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. North America Lansoprazole for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. North America Lansoprazole for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 102. North America Lansoprazole for Injection Sales by Country (2021-2026) & (K Units) Table 103. North America Lansoprazole for Injection Sales by Country (2027-2032) & (K Units) Table 104. North America Lansoprazole for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 105. North America Lansoprazole for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 106. United States Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 107. Canada Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 108. Mexico Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 109. Europe Lansoprazole for Injection Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Lansoprazole for Injection Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Lansoprazole for Injection Sales by Type (2021-2026) & (K Units) Table 112. Europe Lansoprazole for Injection Sales by Type (2027-2032) & (K Units) Table 113. Europe Lansoprazole for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 114. Europe Lansoprazole for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 115. Europe Lansoprazole for Injection Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Lansoprazole for Injection Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Lansoprazole for Injection Sales by Application (2021-2026) & (K Units) Table 118. Europe Lansoprazole for Injection Sales by Application (2027-2032) & (K Units) Table 119. Europe Lansoprazole for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 120. Europe Lansoprazole for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 121. Europe Lansoprazole for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Lansoprazole for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Lansoprazole for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Lansoprazole for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 125. Europe Lansoprazole for Injection Sales by Country (2021-2026) & (K Units) Table 126. Europe Lansoprazole for Injection Sales by Country (2027-2032) & (K Units) Table 127. Europe Lansoprazole for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 128. Europe Lansoprazole for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 129. Germany Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 130. France Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 131. U.K. Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 132. Italy Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 133. Russia Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 134. Spain Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 135. Netherlands Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 136. Switzerland Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 137. Sweden Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 138. Poland Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 139. China Lansoprazole for Injection Revenue by Type (2021-2026) & (US$ Million) Table 140. China Lansoprazole for Injection Revenue by Type (2027-2032) & (US$ Million) Table 141. China Lansoprazole for Injection Sales by Type (2021-2026) & (K Units) Table 142. China Lansoprazole for Injection Sales by Type (2027-2032) & (K Units) Table 143. China Lansoprazole for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 144. China Lansoprazole for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 145. China Lansoprazole for Injection Revenue by Application (2021-2026) & (US$ Million) Table 146. China Lansoprazole for Injection Revenue by Application (2027-2032) & (US$ Million) Table 147. China Lansoprazole for Injection Sales by Application (2021-2026) & (K Units) Table 148. China Lansoprazole for Injection Sales by Application (2027-2032) & (K Units) Table 149. China Lansoprazole for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 150. China Lansoprazole for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 151. Asia Lansoprazole for Injection Revenue by Type (2021-2026) & (US$ Million) Table 152. Asia Lansoprazole for Injection Revenue by Type (2027-2032) & (US$ Million) Table 153. Asia Lansoprazole for Injection Sales by Type (2021-2026) & (K Units) Table 154. Asia Lansoprazole for Injection Sales by Type (2027-2032) & (K Units) Table 155. Asia Lansoprazole for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 156. Asia Lansoprazole for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 157. Asia Lansoprazole for Injection Revenue by Application (2021-2026) & (US$ Million) Table 158. Asia Lansoprazole for Injection Revenue by Application (2027-2032) & (US$ Million) Table 159. Asia Lansoprazole for Injection Sales by Application (2021-2026) & (K Units) Table 160. Asia Lansoprazole for Injection Sales by Application (2027-2032) & (K Units) Table 161. Asia Lansoprazole for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 162. Asia Lansoprazole for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 163. Asia Lansoprazole for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Asia Lansoprazole for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. Asia Lansoprazole for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. Asia Lansoprazole for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 167. Asia Lansoprazole for Injection Sales by Country (2021-2026) & (K Units) Table 168. Asia Lansoprazole for Injection Sales by Country (2027-2032) & (K Units) Table 169. Asia Lansoprazole for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 170. Asia Lansoprazole for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 171. Japan Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 172. South Korea Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 173. India Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 174. Australia Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 175. Taiwan Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 176. Southeast Asia Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 177. SAMEA Lansoprazole for Injection Revenue by Type (2021-2026) & (US$ Million) Table 178. SAMEA Lansoprazole for Injection Revenue by Type (2027-2032) & (US$ Million) Table 179. SAMEA Lansoprazole for Injection Sales by Type (2021-2026) & (K Units) Table 180. SAMEA Lansoprazole for Injection Sales by Type (2027-2032) & (K Units) Table 181. SAMEA Lansoprazole for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 182. SAMEA Lansoprazole for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 183. SAMEA Lansoprazole for Injection Revenue by Application (2021-2026) & (US$ Million) Table 184. SAMEA Lansoprazole for Injection Revenue by Application (2027-2032) & (US$ Million) Table 185. SAMEA Lansoprazole for Injection Sales by Application (2021-2026) & (K Units) Table 186. SAMEA Lansoprazole for Injection Sales by Application (2027-2032) & (K Units) Table 187. SAMEA Lansoprazole for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 188. SAMEA Lansoprazole for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 189. SAMEA Lansoprazole for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. SAMEA Lansoprazole for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. SAMEA Lansoprazole for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. SAMEA Lansoprazole for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 193. SAMEA Lansoprazole for Injection Sales by Country (2021-2026) & (K Units) Table 194. SAMEA Lansoprazole for Injection Sales by Country (2027-2032) & (K Units) Table 195. SAMEA Lansoprazole for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 196. SAMEA Lansoprazole for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 197. Brazil Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 198. Argentina Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 199. Chile Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 200. Colombia Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 201. Peru Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 202. Saudi Arabia Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 203. Israel Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 204. UAE Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 205. Turkey Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 206. Iran Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 207. Egypt Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 208. Key Raw Materials Table 209. Raw Materials Key Suppliers Table 210. Lansoprazole for Injection Distributors List Table 211. Lansoprazole for Injection Customers List Table 212. Research Programs/Design for This Report Table 213. Authors List of This Report Table 214. Secondary Sources Table 215. Primary Sources List of Figures Figure 1. Lansoprazole for Injection Image Figure 2. Global Lansoprazole for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lansoprazole for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. Vial Type Image Figure 5. Ampule Type Image Figure 6. Global Lansoprazole for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Lansoprazole for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Male Image Figure 9. Female Image Figure 10. Global Lansoprazole for Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Lansoprazole for Injection Revenue (2021-2032) & (US$ Million) Figure 12. Global Lansoprazole for Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Lansoprazole for Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Lansoprazole for Injection Revenue Market Share by Region (2021-2032) Figure 15. Global Lansoprazole for Injection Sales (2021-2032) & (K Units) Figure 16. Global Lansoprazole for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Lansoprazole for Injection Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Lansoprazole for Injection Sales YoY (2021-2032) & (K Units) Figure 19. Europe Lansoprazole for Injection Sales YoY (2021-2032) & (K Units) Figure 20. China Lansoprazole for Injection Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Lansoprazole for Injection Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Lansoprazole for Injection Sales YoY (2021-2032) & (K Units) Figure 23. Global Lansoprazole for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Lansoprazole for Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Lansoprazole for Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Lansoprazole for Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Lansoprazole for Injection Revenue Market Share by Type (2021-2032) Figure 29. Global Lansoprazole for Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Lansoprazole for Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Lansoprazole for Injection Sales Market Share by Type (2021-2032) Figure 32. Global Lansoprazole for Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Lansoprazole for Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Lansoprazole for Injection Revenue Market Share by Application (2021-2032) Figure 35. Global Lansoprazole for Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Lansoprazole for Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Lansoprazole for Injection Sales Market Share by Application (2021-2032) Figure 38. North America Lansoprazole for Injection Revenue Share by Type (2021-2032) Figure 39. North America Lansoprazole for Injection Sales Share by Type (2021-2032) Figure 40. North America Lansoprazole for Injection Revenue Share by Application (2021-2032) Figure 41. North America Lansoprazole for Injection Sales Share by Application (2021-2032) Figure 42. North America Lansoprazole for Injection Revenue Share by Country (2021-2032) Figure 43. North America Lansoprazole for Injection Sales Share by Country (2021-2032) Figure 44. Europe Lansoprazole for Injection Revenue Share by Type (2021-2032) Figure 45. Europe Lansoprazole for Injection Sales Share by Type (2021-2032) Figure 46. Europe Lansoprazole for Injection Revenue Share by Application (2021-2032) Figure 47. Europe Lansoprazole for Injection Sales Share by Application (2021-2032) Figure 48. Europe Lansoprazole for Injection Revenue Share by Country (2021-2032) Figure 49. Europe Lansoprazole for Injection Sales Share by Country (2021-2032) Figure 50. China Lansoprazole for Injection Revenue Share by Type (2021-2032) Figure 51. China Lansoprazole for Injection Sales Share by Type (2021-2032) Figure 52. China Lansoprazole for Injection Revenue Share by Application (2021-2032) Figure 53. China Lansoprazole for Injection Sales Share by Application (2021-2032) Figure 54. Asia Lansoprazole for Injection Revenue Share by Type (2021-2032) Figure 55. Asia Lansoprazole for Injection Sales Share by Type (2021-2032) Figure 56. Asia Lansoprazole for Injection Revenue Share by Application (2021-2032) Figure 57. Asia Lansoprazole for Injection Sales Share by Application (2021-2032) Figure 58. Asia Lansoprazole for Injection Revenue Share by Country (2021-2032) Figure 59. Asia Lansoprazole for Injection Sales Share by Country (2021-2032) Figure 60. SAMEA Lansoprazole for Injection Revenue Share by Type (2021-2032) Figure 61. SAMEA Lansoprazole for Injection Sales Share by Type (2021-2032) Figure 62. SAMEA Lansoprazole for Injection Revenue Share by Application (2021-2032) Figure 63. SAMEA Lansoprazole for Injection Sales Share by Application (2021-2032) Figure 64. SAMEA Lansoprazole for Injection Revenue Share by Country (2021-2032) Figure 65. SAMEA Lansoprazole for Injection Sales Share by Country (2021-2032) Figure 66. Lansoprazole for Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Lansoprazole for Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Vial Type
  • Ampule Type
Applications
  • Male
  • Female
Companies covered
  • Maya Biotech
  • Chengdu Baiyu Pharmaceutical
  • Jiangsu Aosaikang Pharmaceutical
  • Luoxin Pharmaceutical
  • Takeda
  • Yuekang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lansoprazole for Injection Market by Type
  3. 1.2.1 Global Lansoprazole for Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Vial Type
  5. 1.2.3 Ampule Type
  6. 1.3 Lansoprazole for Injection Market by Application
  7. 1.3.1 Global Lansoprazole for Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Male
  9. 1.3.3 Female
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Lansoprazole for Injection Market Dynamics
  1. 2.1 Lansoprazole for Injection Industry Trends
  2. 2.2 Lansoprazole for Injection Industry Drivers
  3. 2.3 Lansoprazole for Injection Industry Opportunities and Challenges
  4. 2.4 Lansoprazole for Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Lansoprazole for Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Lansoprazole for Injection Revenue by Region
  3. 3.2.1 Global Lansoprazole for Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lansoprazole for Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Lansoprazole for Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Lansoprazole for Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Lansoprazole for Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Lansoprazole for Injection Sales by Region
  9. 3.4.1 Global Lansoprazole for Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Lansoprazole for Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Lansoprazole for Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Lansoprazole for Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Lansoprazole for Injection Revenue by Manufacturers
  2. 4.1.1 Global Lansoprazole for Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Lansoprazole for Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Lansoprazole for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lansoprazole for Injection Sales by Manufacturers
  6. 4.2.1 Global Lansoprazole for Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Lansoprazole for Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Lansoprazole for Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Lansoprazole for Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Lansoprazole for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Lansoprazole for Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Lansoprazole for Injection Manufacturers, Product Type & Application
  13. 4.7 Global Lansoprazole for Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Lansoprazole for Injection Market CR5 and HHI
  16. 4.8.2 2025 Lansoprazole for Injection Tier 1, Tier 2, and Tier 3
5 Lansoprazole for Injection Market by Type
  1. 5.1 Global Lansoprazole for Injection Revenue by Type
  2. 5.1.1 Global Lansoprazole for Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Lansoprazole for Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Lansoprazole for Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Lansoprazole for Injection Sales by Type
  6. 5.2.1 Global Lansoprazole for Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lansoprazole for Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Lansoprazole for Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Lansoprazole for Injection Price by Type
6 Lansoprazole for Injection Market by Application
  1. 6.1 Global Lansoprazole for Injection Revenue by Application
  2. 6.1.1 Global Lansoprazole for Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Lansoprazole for Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Lansoprazole for Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Lansoprazole for Injection Sales by Application
  6. 6.2.1 Global Lansoprazole for Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Lansoprazole for Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Lansoprazole for Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Lansoprazole for Injection Price by Application
7 Company Profiles
  1. 7.1 Maya Biotech
  2. 7.1.1 Maya Biotech Company Information
  3. 7.1.2 Maya Biotech Business Overview
  4. 7.1.3 Maya Biotech Lansoprazole for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Maya Biotech Lansoprazole for Injection Product Portfolio
  6. 7.1.5 Maya Biotech Recent Developments
  7. 7.2 Chengdu Baiyu Pharmaceutical
  8. 7.2.1 Chengdu Baiyu Pharmaceutical Company Information
  9. 7.2.2 Chengdu Baiyu Pharmaceutical Business Overview
  10. 7.2.3 Chengdu Baiyu Pharmaceutical Lansoprazole for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Chengdu Baiyu Pharmaceutical Lansoprazole for Injection Product Portfolio
  12. 7.2.5 Chengdu Baiyu Pharmaceutical Recent Developments
  13. 7.3 Jiangsu Aosaikang Pharmaceutical
  14. 7.3.1 Jiangsu Aosaikang Pharmaceutical Company Information
  15. 7.3.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  16. 7.3.3 Jiangsu Aosaikang Pharmaceutical Lansoprazole for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Jiangsu Aosaikang Pharmaceutical Lansoprazole for Injection Product Portfolio
  18. 7.3.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  19. 7.4 Luoxin Pharmaceutical
  20. 7.4.1 Luoxin Pharmaceutical Company Information
  21. 7.4.2 Luoxin Pharmaceutical Business Overview
  22. 7.4.3 Luoxin Pharmaceutical Lansoprazole for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Luoxin Pharmaceutical Lansoprazole for Injection Product Portfolio
  24. 7.4.5 Luoxin Pharmaceutical Recent Developments
  25. 7.5 Takeda
  26. 7.5.1 Takeda Company Information
  27. 7.5.2 Takeda Business Overview
  28. 7.5.3 Takeda Lansoprazole for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Takeda Lansoprazole for Injection Product Portfolio
  30. 7.5.5 Takeda Recent Developments
  31. 7.6 Yuekang Pharmaceutical
  32. 7.6.1 Yuekang Pharmaceutical Company Information
  33. 7.6.2 Yuekang Pharmaceutical Business Overview
  34. 7.6.3 Yuekang Pharmaceutical Lansoprazole for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Yuekang Pharmaceutical Lansoprazole for Injection Product Portfolio
  36. 7.6.5 Yuekang Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Lansoprazole for Injection Market Size by Type
  2. 8.1.1 North America Lansoprazole for Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Lansoprazole for Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Lansoprazole for Injection Price by Type (2021-2032)
  5. 8.2 North America Lansoprazole for Injection Market Size by Application
  6. 8.2.1 North America Lansoprazole for Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Lansoprazole for Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Lansoprazole for Injection Price by Application (2021-2032)
  9. 8.3 North America Lansoprazole for Injection Market Size by Country
  10. 8.3.1 North America Lansoprazole for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Lansoprazole for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Lansoprazole for Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Lansoprazole for Injection Market Size by Type
  2. 9.1.1 Europe Lansoprazole for Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Lansoprazole for Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Lansoprazole for Injection Price by Type (2021-2032)
  5. 9.2 Europe Lansoprazole for Injection Market Size by Application
  6. 9.2.1 Europe Lansoprazole for Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Lansoprazole for Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Lansoprazole for Injection Price by Application (2021-2032)
  9. 9.3 Europe Lansoprazole for Injection Market Size by Country
  10. 9.3.1 Europe Lansoprazole for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Lansoprazole for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Lansoprazole for Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Lansoprazole for Injection Market Size by Type
  2. 10.1.1 China Lansoprazole for Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Lansoprazole for Injection Sales by Type (2021-2032)
  4. 10.1.3 China Lansoprazole for Injection Price by Type (2021-2032)
  5. 10.2 China Lansoprazole for Injection Market Size by Application
  6. 10.2.1 China Lansoprazole for Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Lansoprazole for Injection Sales by Application (2021-2032)
  8. 10.2.3 China Lansoprazole for Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lansoprazole for Injection Market Size by Type
  2. 11.1.1 Asia Lansoprazole for Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Lansoprazole for Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Lansoprazole for Injection Price by Type (2021-2032)
  5. 11.2 Asia Lansoprazole for Injection Market Size by Application
  6. 11.2.1 Asia Lansoprazole for Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Lansoprazole for Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Lansoprazole for Injection Price by Application (2021-2032)
  9. 11.3 Asia Lansoprazole for Injection Market Size by Country
  10. 11.3.1 Asia Lansoprazole for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Lansoprazole for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Lansoprazole for Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lansoprazole for Injection Market Size by Type
  2. 12.1.1 SAMEA Lansoprazole for Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Lansoprazole for Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Lansoprazole for Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Lansoprazole for Injection Market Size by Application
  6. 12.2.1 SAMEA Lansoprazole for Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Lansoprazole for Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Lansoprazole for Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Lansoprazole for Injection Market Size by Country
  10. 12.3.1 SAMEA Lansoprazole for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Lansoprazole for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Lansoprazole for Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Lansoprazole for Injection Value Chain Analysis
  2. 13.1.1 Lansoprazole for Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Lansoprazole for Injection Production Mode & Process
  6. 13.2 Lansoprazole for Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Lansoprazole for Injection Distributors
  9. 13.2.3 Lansoprazole for Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research